Organon & Co. received an analyst rating update and filed with the SEC regarding institutional holdings.

The entities involved

• Organon & Co. →

  pharmaceutical company

  • Organon & Co. and Spero Therapeutics Inc., two healthcare companies, are currently competing for investment opportunities.Wed 11:24
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12

Related events

• Analyst upgraded Ironwood Pharmaceuticals to 'hold' rating, concurrent with insider selling disclosures filed with the SEC.Sat 10:54
• Analyst downgrades are affecting the stock valuation of Atlanta Braves, which has filed disclosures with the SEC.Sep 17
• Analyst downgraded price objective and rating for Lennar Corporation, filing required reports with the SEC.Sep 7
• Moderna stock activity, including institutional purchases and analyst ratings, was disclosed to the SEC.Sep 9
• Analyst ratings disclosed via SEC filing involving Morgan Stanley, Royal Bank of Canada, and the SEC.Jun 26